KevinDJudyMDMBA

Clinical Trials

• Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme Start of enrollment: 2005 Oct 01

  Completed

  Phase 1

• Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma Start of enrollment: 2001 Jul 01

  Terminated

  Not Applicable

• Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2006 Nov 01

  Completed

  Phase 1

• Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09

  Completed

  Phase 1

• Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

  Withdrawn

  Phase 1

• Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas Start of enrollment: 2015 Jan 30

  Completed

  Phase 1

• Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues Start of enrollment: 2021 Feb 03

  Recruiting

  Roles: Principal Investigator, Contact

• A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma Start of enrollment: 2023 Mar 20

  Active, not recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• Join now to see all